22nd Century Group (NAS:XXII) Change In Payables And Accrued Expense

: $0.74 Mil (TTM As of Dec. 2022)

View and export this data going back to 2011. Start your Free Trial

22nd Century Group's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2022 was $0.01 Mil. It means 22nd Century Group's Accounts Payable & Accrued Expense increased by $0.01 Mil from Sep. 2022 to Dec. 2022 .

22nd Century Group's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was $0.74 Mil. It means 22nd Century Group's Accounts Payable & Accrued Expense increased by $0.74 Mil from Dec. 2021 to Dec. 2022 .

22nd Century Group Change In Payables And Accrued Expense Historical Data

The historical data trend for 22nd Century Group's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

22nd Century Group Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

0.16

0.06

1.25

0.17

0.74

22nd Century Group Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Change In Payables And Accrued Expense																1.30	-1.13	0.74	1.11	0.01

22nd Century Group Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.74 Mil.

22nd Century Group Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of 22nd Century Group's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

22nd Century Group (NAS:XXII) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » 22nd Century Group Inc (NAS:XXII) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Seneca Street, Suite 507, Buffalo, NY, USA, 14204

Website

https://www.xxiicentury.com

22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales, and distribution of SPECTRUM and VLN proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos, and among others.

Executives

John J Miller	officer: President, Tobacco	500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Lucille S Salhany	director	C/O HEWLETT-PACKARD CO, 3000 HANOVER STREET, PALO ALTO CA 94304
Robert Hugh Kinsman	officer: Chief Financial Officer	500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Clifford B Fleet	director	6601 WEST BROAD STREET, RICHMOND VA 23230
Richard F Fitzgerald	officer: Chief Financial Officer	C/O TECHPRECISION CORPORATION, ONE BELLA DRIVE, WESTMINSTER MA 01473
Anthony L. Johnson	director	C/O 22ND CENTURY GROUP, INC., 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Michael Koganov	director	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
James A Mish	officer: Chief Executive Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
John Franzino	officer: CFO	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Roger D O'brien	director	C/O 22ND CENTURY GROUP, INC., 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Andrea S Jentsch	officer: Chief Financial Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Michael Zercher	officer: Chief Operating Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
James E. Swauger	officer: Senior VP-Science & Regulatory	C/O 22ND CENTURY GROUP, INC., 9530 MAIN STREET, CLARENCE NY 14031
Paul Rushton	officer: VP of Plant Biotechnology	C/O 22ND CENTURY GROUP, INC., 9530 MAIN STREET, CLARENCE NY 14031
Nora B Sullivan	director	C/O RAND CAPITAL CORP, 2200 RAND BLDG, BUFFALO NY 14203